Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice
- 1 October 1994
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 95 (3) , 223-233
- https://doi.org/10.1007/bf01271568
Abstract
We have previously observed that an N-methyl-D-aspartate (NMDA) antagonist in combination with the α 2-adrenoceptor agonist clonidine produces a marked locomotor stimulation in monoamine-depleted mice. In this paper we report on how the partial glycine agonists D-cycloserine (high intrinsic activity) and (+)-HA-966 [(+)-3-amino-1-hydroxypyrrolid-2-one; low intrinsic activity] affect this response; the interaction with both an uncompetitive and a competitive NMDA antagonist was investigated. (+)-HA-966 was found to counteract the locomotor stimulation produced by clonidine combined with either an uncompetitive (MK-801=dizocilpine) or a competitive [D-CPPene=3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid] NMDA antagonist. D-cycloserine potentiated the locomotor stimulation produced by either NMDA antagonist combined with clonidine, although statistical significance was achieved only in the case of MK-801. If the present hyperactivity model has any relevance for psychosis the prediction based on the present results would be that d-cycloserine, contrary to current hopes, might not be so effective in schizophrenia, whereas (+)-HA-966 might be an interesting candidate.Keywords
This publication has 32 references indexed in Scilit:
- Are the disparate pharmacological profiles of competitive and un-competitive NMDA antagonists due to different baseline activities of distinct glutamatergic pathways? (Hypothesis)Journal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993
- The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behaviorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1992
- Sites for Antagonism on the N-Methyl-D-Aspartate Receptor Channel ComplexAnnual Review of Pharmacology and Toxicology, 1991
- An Open-Label Trial of Milacemide in SchizophreniaClinical Neuropharmacology, 1990
- Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's diseaseTrends in Neurosciences, 1990
- The Glycine Site of the N‐Methyl‐D‐Aspartate Receptor Channel: Differences Between the Binding of HA‐966 and of 7‐Chlorokynurenic AcidJournal of Neurochemistry, 1990
- The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted miceLife Sciences, 1990
- Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted miceJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- A “Glutamatergic Hypothesis” of SchizophreniaClinical Neuropharmacology, 1989
- demonstration of the enhancement of MK-801 by L-glutamateLife Sciences, 1989